Cyclacel is a clinical-stage biopharmaceutical company that develops innovative cancer medicines based on cell cycle biology, transcriptional regulation, and epigenetics. It focuses on creating therapies to combat cancer resistance and enhance the body's ability to destroy cancer cells.